TI
BIIB icon

Telemetry Investments’s Biogen BIIB Stock Holding History

Telemetry Investments’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$226K Buy
+817
New +$231K 0.36% 68

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Telemetry Investments's BIIB Position: Q4 2022 in Review

Telemetry Investments opened a new position in Biogen (BIIB) in Q4 2022: 817 shares worth $226K. The stake represents 0.36% of the portfolio and ranks #68 among its holdings.

1,031 funds tracked by Wall St. Rank hold BIIB as of Q4 2022.

  • Telemetry Investments held 817 shares of Biogen worth $226K as of Q4 2022.
  • Biogen was a new Telemetry Investments position in Q4 2022.
  • Biogen made up 0.36% of Telemetry Investments's portfolio in Q4 2022, its #68 holding.
  • 1,031 funds tracked by Wall St. Rank held Biogen as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.